Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Study Shows New Non-Invasive Device Screens Diabetes Better Than Fasting Plasma Glucose Test
Posted: Friday, June 30, 2006
Researchers reported a new non-invasive technology that uses fluorescent light to detect the presence of abnormal concentrations of diabetes-related biological markers found in skin was able to significantly outperform fasting plasma glucose (FPG) as a screening test for pre-diabetes and type 2 diabetes.

New Agent Reduces Risk of Diabetic Retinopathy
Posted: Friday, June 23, 2006
A protein kinase C-beta inhibitor reduced the risk of sustained vision loss and progression of diabetic macular edema in two phase III trials, researchers announced.



New Test for Insulin Resistance
Posted: Friday, June 23, 2006
Lowering blood levels of a protein found in higher quantities among those with insulin resistance might cut the risk of diabetes, metabolic syndrome and cardiovascular disease, a new study suggests. Raised levels of the protein in the blood may provide an early warning sign of the development of type 2 diabetes.

Investigational Januvia (MSD) Put Through Its Paces for Diabetes
Posted: Thursday, June 15, 2006
Researchers reported that, Januvia (sitagliptin), an investigational oral agent for type 2 diabetes, appears to be effective when given as a monotherapy or as an adjunct to Glucophage (metformin) or Actos (pioglitazone). FDA approval expected soon.

New Oral Insulin Shows Safety, Feasibility in Trials
Posted: Thursday, June 15, 2006
In the first human trials of oral insulin, the drug acted within 15 minutes and showed 60%-70% of the biopotency of injected insulin, without causing any adverse effects, researchers reported here at the 66th Scientific Sessions of the American Diabetes Association.



Study Shows New Non-Invasive Device Screens Diabetes Better Than Fasting Plasma Glucose Test
Posted: Thursday, June 15, 2006
Diabetes biomarkers found in skin shown to Correlate well with diabetes risk.

Many Doctors Aren't Treating Diabetes Aggressively Enough
Posted: Thursday, June 15, 2006
FOUR studies find that this is true for patients with high blood pressure, and elevated blood sugar.

Once-Weekly BYETTA (Exenatide) LAR Improves Glucose Control in Patients with Type 2 Diabetes
Posted: Thursday, June 15, 2006
Reduces A1c by 2 points and average weight lose of 8 pounds in 15 weeks.

High Postmenopausal Sex Hormones Signal Type 2 Diabetes Risk
Posted: Thursday, June 15, 2006
Postmenopausal women with high levels of estradiol and testosterone are at a greatly increased risk of developing type 2 diabetes, according to data on nearly 28,000 women.

Women with Preeclampsia Have Double the Type 2 Diabetes Risk
Posted: Thursday, June 15, 2006
Researchers reported that preeclampsia is an independent risk marker for type 2 diabetes, even when gestational diabetes is taken into account.

Page 250 of 266
 |<   <<   <  245  |  246  |  247  |  248  |  249  |  250  |  251  |  252  |  253  |  254  |  255  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement